Results 281 to 290 of about 10,999,138 (370)
Objectives This study aims to develop hip morphology‐based radiographic hip osteoarthritis (RHOA) risk prediction models and investigates the added predictive value of hip morphology measurements and the generalizability to different populations. Methods We combined data from nine prospective cohort studies participating in the World COACH consortium ...
Myrthe A. van den Berg +26 more
wiley +1 more source
Response to letter regarding iTr35 cells a novel immunoregulatory subset involved in bone loss in rheumatoid arthritis and clinical implications. [PDF]
Li Y, An M, Yao L, Lu J.
europepmc +1 more source
REACT Framework in Contextualizing Lesson in General Biology 2 in Fostering Scientific Creativity
Joshua Philip T. Pirante, Elisa N. Chua
openalex +2 more sources
Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database. [PDF]
Bruins MJ +3 more
europepmc +1 more source
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth +19 more
wiley +1 more source
Collaborative and co-Ordinated action for Medication Safety (COMS): Experience-based co-design of an intervention blueprint to improve general practice and community pharmacy collaboration. [PDF]
Lewis PJ +10 more
europepmc +1 more source
Objective This study aimed to identify in patients with systemic lupus erythematosus (SLE) with clinically active disease the attainment of frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao +39 more
wiley +1 more source

